B cell abnormalities identified as potential biomarkers for triple negative breast cancer treatment response

  • Post author:
  • Post category:uncategorized

Researchers at Baylor College of Medicine and collaborating institutions have discovered new insights into tumor-induced B cell changes in blood and bone marrow of triple negative breast cancer patients.